Focused TTE for Hemodynamic Instable High Risk Patients
Intraoperative Focused TTE - Impact on High Risk Patients´ Management in Hemodynamic Instabilities
1 other identifier
interventional
50
1 country
1
Brief Summary
Focused transthoracic echocardiography (TTE) is a technique, which allows quick and non-invasive diagnosis and monitoring in hemodynamic instable patients. There are preliminary data supporting the hypothesis that TTE is feasible in the operating theatre. The purpose of this study is to test the hypothesis that intraoperative focused TTE has an impact on high risk patients´ management when it is added to standard extended monitoring practices in hemodynamic instabilities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 13, 2013
CompletedFirst Posted
Study publicly available on registry
March 15, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedApril 17, 2014
April 1, 2014
8 months
March 13, 2013
April 16, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of patients´ management
Recordings of TTE findings influencing change of patient´s management in the operating theatre
at time of anesthesia / surgery
Study Arms (1)
intraoperative TTE
EXPERIMENTALTTE if a hemodynamic instability occurs
Interventions
Eligibility Criteria
You may qualify if:
- gender: male, female
- Age ≥ 18 years
- increased perioperative risk, at least one of the following:
- coronary artery disease
- congestive heart disease
- insulin dependent diabetes mellitus
- renal insufficiency, creatinine \> 2,0 mg/dl
- cerebrovascular disease
- Sepsis
- Procedure with at least moderate increased risk
- intraperitoneal surgery
- intrathoracal surgery
- major orthopedic/traumatologic surgery
- prostatic surgery
- vascular surgery
- +4 more criteria
You may not qualify if:
- cardiac surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kerckhoff Heart Centercollaborator
- Philipps University Marburglead
Study Sites (1)
University Hospital of Marburg, Department of Anesthesia
Marburg, D-35033, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Kratz, MD
Department of Anesthesia and Intensive Care Medicine, University Hospital Marburg, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Thomas Kratz
Study Record Dates
First Submitted
March 13, 2013
First Posted
March 15, 2013
Study Start
March 1, 2013
Primary Completion
November 1, 2013
Study Completion
March 1, 2014
Last Updated
April 17, 2014
Record last verified: 2014-04